Font Size: a A A

Based On The Perspective Of The Financial Statements Under The Tiantan Biological Co.,Ltd.,Growth Research

Posted on:2015-01-16Degree:MasterType:Thesis
Country:ChinaCandidate:X Y ZhangFull Text:PDF
GTID:2309330467469779Subject:Accounting
Abstract/Summary:PDF Full Text Request
In recent years, along with the rapid increase in listed companies and the pharmaceutical industry as an important part of the national economy are increased rapidly. Although the boom of the pharmaceutical industry and will continue to keep high, but not all them can ride high lift and rapid growth. Listed companies in the industry also is the good and bad are intermingled, how to determine the growth of them are many envelopes value investment idea that the investors should be concerned about important issues. Financial statement analysis as a main tool to analysis enterprise financial conditions in building enterprise growth financial indicators play a very important role, so based on the perspective of financial statements under the influence factors of affecting enterprise growth within the main factors in the majority, but there are a variety of growth factors. Including the impact of the financial aspects of not only, still include non-financial effects.In this paper by using the enterprise growing value, enterprise growth evaluation as well as the enterprise life cycle and other relevant theories and research methods and combining the related theory. Enterprise financial statements to build the influence of pharmaceutical listed companies growth index evaluation system. Based on financial statements reflect the data, by using different ways to report data analysis affecting enterprise growth of financial indicators. Mainly according to the characteristics of the biological medicine company, build growth from the aspects of financial and non-financial indicators evaluation system. Financial index mainly includes4first-level indicators and10secondary indicators, non-financial indicators include four, respectively to the state policy, market environment, the company size and the capacity for independent innovation. And through the factor analysis evaluation method and statistical software SPASS verification, analyze its growth. By studying can learn about the company scale, market demand, national policy, the independent innovation ability also can affect the growth of an enterprise. Through the growth index system construction and the use of factor analysis to evaluate index shows the influence of each index for a growing correlation degree. Comprehensive analysis of the internal and external factors influencing the enterprise growth. Through the construction of pharmaceutical listed companies growth index evaluation system and combined with the Tiantan biological co., Ltd., case studies. Find out problems and reasons of influencing the enterprise growth and puts forward the countermeasures and suggestions to solve the problems. Find out problems and reasons of influencing the enterprise growth and puts forward the countermeasures and suggestions to solve the problems. This is not only beneficial to enterprise industrial structure adjustment, improve profitability; Also benefit companies continue to improve management, improve market competition ability and continuously in the biological medicine industry development, so as to grow.
Keywords/Search Tags:Financial statement analysis, Pharmaceutical listed enterprise, Growth value, Growthevaluation
PDF Full Text Request
Related items